Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 7.9.2015 | EN | Official Journal of the European Union | C 294/79 |

---

Action brought on 30 June 2015 — Alpex Pharma v OHIM — Astex Pharmaceuticals (ASTEX)

(Case T-355/15)

(2015/C 294/95)

Language in which the application was lodged: English

Parties

Applicant: Alpex Pharma SA (Mezzovico-Vira, Switzerland) (represented by: C. Bacchini and M. Mazzitelli, lawyers)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs) (OHIM)

Other party to the proceedings before the Board of Appeal: Astex Pharmaceuticals, Inc. (Pleasanton, United States)

Details of the proceedings before OHIM

Applicant: The other party to the proceedings before the Board of Appeal

Trade mark at issue: Community word mark ‘ASTEX’ — Application for registration No 1 0 8 05  281

Procedure before OHIM: Opposition proceedings

Contested decision: Decision of the Second Board of Appeal of OHIM of 28 April 2015 in Case R 593/2014-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order OHIM and the other party to the proceedings before the Board of Appeal, should it intervene, to pay the costs. |

Plea in law

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)